Current EventOverview Day 1Day 2Day 3 Short CoursePDF Download Hotel & Travel Distinguished Faculty Sponsor & Exhibits Press Pass Request Brochure Archives
microRNA Identification, Profiling and Validation Techniques DVD
March 22, 2010
About the DVD:The role of microRNA in regulating mammalian development and disease is now well established. miRNAs represent a novel class of targets for therapeutic and diagnostic development, currently not fully exploited by the pharmaceutical and biotechnology industries. This DVD features expert speakers in the pre-conference short course from CHI’s microRNA in Human Disease and Development 2010 meeting addressing technologies used for miRNA identification, profiling and validation involving microarrays, PCR, informatics, etc. Click here for more info
CONFERENCE OVERVIEW:
TOPICS INCLUDE:
PRE-CONFERENCE SHORT COURSE:
microRNA Identification, Profiling and Validation Techniques
MONDAY, MARCH 22 * 8:00am – 12:00pm
Direct, Electronic microRNA Profiling on a Multiplexed Chip
Shana O. Kelley, Ph.D., Professor, Biochemistry, University of Toronto
The Regulation of microRNA Biogenesis in Cancer and Development
J. Michael Thomson, Ph.D., Assistant Professor, Department of Cancer Biology, Vanderbilt-Ingram Cancer Center
Integrating Micro, Messenger and Non-Coding RNA Expression Analysis via a Single Array Profiling Platform
Xiaolian Gao, Ph.D., Professor, Biology and Biochemistry, Chemistry, and Biomedical Engineering, Biology and Biochemistry, University of Houston
High-Content Assay to Screen for Modulators of the miRNA Machinery
David Shum, Ph.D., Assay Development Specialist, HTS Core Facility, Memorial Sloan Kettering Cancer Center
Nuclear miRNAs and Cytoplasmic miRNAs
Clark Jeffries, Ph.D., Research Professor, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
microRNAs and Breast Cancer Metastasis: The Power of Pleiotropy
Scott Valastyan, Ph.D., Laboratory of Robert A. Weinberg, Massachusetts Institute of Technology and Whitehead Institute for Biomedical Research
Development and Validation of a miRNA-Based Laboratory Developed Test (LDT) for Pancreatic Cancer
Anna Szafranska-Schwarzbach, Ph.D., CLIA Laboratory Supervisor, Pharmacogenomics Services, Asuragen, Inc.
Technology Showcase:
Sponsored byDiscovery of miRNA-Based Biomarkers for Colon Cancer
Søren Møller, Ph.D., Vice President, Product Development, Exiqon A/S
Title Sponsored byTo be AnnouncedThomas Schmittgen, Ph.D., Associate Professor, Division of Pharmaceutics, College of Pharmacy, Ohio State University
Sponsored by
miRNA Biomarker Profiling from Blood: A Promising Approach for Non-Invasive Diagnostic Testing
Peer Staehler, VP Marketing and CSO, febit, Inc.
Sponsored bymiRNA Profiling in Context: miRNA and mRNA Profiling of the NCI-60 on the Agilent Microarray Platform
Stephanie Fulmer-Smentek, Ph.D., RNA Applications, R&D Group Manager, Biological Systems Division, Agilent Technologies
nCounter™ Analysis System: A Complete Solution for Detecting and Counting Large Sets of Target miRNA, mRNA, and DNA Molecules in Biological Samples Using Color Coded TagsStephen Jackson Ph.D., Field Application Scientist, NanoString Technologies, Inc.
Sustained Overexpression of miRNA Mimics using a Lentiviral Delivery SystemEmily Anderson, Research Scientist, Thermo Scientific Genomics
High-Throughput Functional Screening for miRNA TargetsPatrick Collins, Ph.D., Director of Research and Development, Switchgear Genomics